,Date,Study,Study Link,Journal,Days After Admission Covid-19 is Present,Source / Summary,Study Type,Sample Size,Confirmation
0,2020-04-03,"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study",https://www.sciencedirect.com/science/article/pii/S0140673620305663?casa_token=At8bltLokFMAAAAA:EZEVZRa9aH-LFUs4mrJsE45Ww8EnPcCGZrdB5MSV0IcEPfmVchwvUSgkDGHIkIj6qO6JvYxH8Lw,The Lancet,8-37 DAO (median = 20),"Median shedding with lopinavir/ritonavir = 22 days, median in severe cases = 22 days, median in critical cases = 24 days",Retrospective cohort,n=29,RT-PCR confirmed
1,2020-03-30,Virus shedding patterns in nasopharyngeal and fecal specimens of COVID-19 patients,https://www.medrxiv.org/content/10.1101/2020.03.28.20043059v1,medRxiv,median=10 DAO,Viral titers of nasal-throat swabs peaked at 6-9 DAO,,n=23,RT-PCR confirmed
2,2020-03-26,Viral Kinetics and Antibody Responses in Patients with COVID-19,https://doi.org/10.1101/2020.03.24.20042382,medRxiv,3-38 DAO (median =12),Nasophayngeal is a major shedding area.,Prospective Cohort,n=67,qRT-PCR confirmed
3,2020-03-19,Viral dynamics in mild and severe cases of COVID-19,https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30232-2/fulltext,The Lancet Infectious Disease,"Mild ~15 DAO, Severe ~25 DAO","Mild illness cleared by ~10 DAO, severe cases last longer.",,n=76,RT-PCR confirmed
4,2020-03-15,Evaluation of SARS-CoV-2 RNA shedding in clinical specimens and clinical characteristics of 10 patients with COVID-19 in Macau,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098032/,International Journal of Biological Sciences,24 DAO,Average RNA conversion time for NPS is 18.2 days (SD: 4.6),Prospective Cohort,n=10,RT-PCR confirmed
5,2020-03-03,Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore,https://doi.org/10.1001/jama.2020.3204,JAMA,1-24 DAO (median 12),83% of patients had nasopharynx viral shedding >7 days,Descriptive case series,n=18,RT-PCR confirmed
